Top compounds associated with response to IPO4


Feature Type Standardized
Nominal ANOVA
mRNA FK866 CTRPv2 pan-cancer AAC 0.043 0.3
mRNA parbendazole CTRPv2 pan-cancer AAC 0.035 0.3
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA KPT185 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.06 0.3
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC -0.062 0.3
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.034 0.3
Download CSV